Suzanne R. Kesten

951 citations

16 papers · 771 indexed · h-index 11

Organic Chemistry top 5%
Molecular Biology
Pharmacology top 5%
Cellular and Molecular Neuroscience top 10%
Oncology

Co-authors: Lawrence D. Wise Thomas G. Heffner Thomas A. Pugsley Jonathan L. Wright Stephen J. Johnson Kim Zoski Thomas R. Belliotti David J. Wustrow
Topics: Neuroscience and Neuropharmacology Research (5 papers)Receptor Mechanisms and Signaling (5 papers)Pharmacological Receptor Mechanisms and Effects (4 papers)
Cited by: Toxicology Organic Chemistry Pharmacology
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Tetrahedron Letters
Partner nations: United States

In The Last Decade

Suzanne R. Kesten

16 papers receiving 742 citations

Peers

Countries citing papers authored by Suzanne R. Kesten

Since Specialization

Citations

This map shows the geographic impact of Suzanne R. Kesten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne R. Kesten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne R. Kesten more than expected).

Fields of papers citing papers by Suzanne R. Kesten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne R. Kesten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne R. Kesten. The network helps show where Suzanne R. Kesten may publish in the future.

Co-authorship network of co-authors of Suzanne R. Kesten

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne R. Kesten. A scholar is included among the top collaborators of Suzanne R. Kesten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne R. Kesten. Suzanne R. Kesten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor 2010 ·ACS Medicinal Chemistry Letters ·Douglas S. Johnson,Cory M. Stiff,Scott E. Lazerwith,Suzanne R. Kesten,(unknown),Mark J. Morris,David Beidler,Marya Liimatta,Sarah E. Smith,David T. Dudley,Nalini Sadagopan,Shobha Bhattachar,S. Kesten,Tyzoon Nomanbhoy,Benjamin F. Cravatt,Kay Ahn	148
2	Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Douglas S. Johnson,Kay Ahn,Suzanne R. Kesten,Scott E. Lazerwith,Yuntao Song,Mark J. Morris,(unknown),Tracy F. Gregory,Cory M. Stiff,James B. Dunbar,Marya Liimatta,David Beidler,Sarah E. Smith,Tyzoon Nomanbhoy,Benjamin F. Cravatt	59
3	The efficient synthesis of (3R,4R,5R)-3-amino-4,5-dimethyl-octanoic acid, a chiral β-amino acid with potent affinity for the α2δ protein 2009 ·Tetrahedron Letters ·Ji Zhang,(unknown),Derek A. Pflum,(unknown),(unknown),Norman L. Colbry,Garrett Hoge,(unknown),Brian Samas,Timothy T. Curran,(unknown),Paul D. Johnson,Suzanne R. Kesten,Jacob B. Schwarz,(unknown),Mark S. Plummer,(unknown),Yun Huang,Michael Lovdahl,Andrew Thorpe	8
4	Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sham S. Nikam,Jon L. Wright,Suzanne R. Kesten,Leonard T. Meltzer,Linda L. Coughenour,(unknown),Kevin A. Serpa,(unknown)	7
5	Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines 2000 ·Journal of Medicinal Chemistry ·Jonathan L. Wright,Tracy F. Gregory,Suzanne R. Kesten,Peter A. Boxer,Kevin A. Serpa,Leonard T. Meltzer,Lawrence D. Wise,Stephen Espitia,Christopher S. Konkoy,Edward R. Whittemore,Richard M. Woodward	95
6	Synthesis of N-Substituted 4-(4-Hydroxyphenyl)piperidines, 4-(4-Hydroxybenzyl)piperidines, and (±)-3-(4-Hydroxyphenyl)pyrrolidines: Selective Antagonists at the 1a/2B NMDA Receptor Subtype 2000 ·Journal of Medicinal Chemistry ·Anthony P. Guzikowski,Amir P. Tamiz,(unknown),(unknown),Sui Xiong Cai,Jon E. Hawkinson,John F. W. Keana,Suzanne R. Kesten,(unknown),Minhtam Tran,Edward R. Whittemore,Richard M. Woodward,Jon L. Wright,Zhang‐Lin Zhou	35
7	Design, Synthesis, and Evaluation of Chromen-2-ones as Potent and Selective Human Dopamine D4 Antagonists 1999 ·Journal of Medicinal Chemistry ·Suzanne R. Kesten,Thomas G. Heffner,Stephen J. Johnson,Thomas A. Pugsley,Jonathan L. Wright,Lawrence D. Wise	99
8	Isoindolinone enantiomers having affinity for the dopamine D4 receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,(unknown),Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Kim Zoski,Steven Z. Whetzel,Ann E. Corbin,Thomas A. Pugsley,Thomas G. Heffner,Lawrence D. Wise	194
9	Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors 1998 ·Journal of Medicinal Chemistry ·David J. Wustrow,Thomas R. Belliotti,Shelly A. Glase,Suzanne R. Kesten,(unknown),Norman L. Colbry,(unknown),A. C. Blackburn,Hyacinth C. Akunne,Ann E. Corbin,M. Duff Davis,Lynn M. Georgic,Steven Z. Whetzel,Kim Zoski,Thomas G. Heffner,Thomas A. Pugsley,Lawrence D. Wise	25
10	Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands 1997 ·Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Lynn M. Georgic,Kim Zoski,Hyacinth C. Akunne,Lawrence D. Wise	15
11	Novel small molecule neurotensin antagonists: 3-(1,5-diaryl-1,5-dioxopentan-3-yl)benzoic acids 1997 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Hyacinth C. Akunne,Thomas G. Heffner,Suzanne R. Kesten,Thomas A. Pugsley,Lawrence D. Wise,David J. Wustrow	3
12	4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonists 1996 ·Bioorganic & Medicinal Chemistry Letters ·Shelly A. Glase,Hyacinth C. Akunne,Thomas G. Heffner,Stephen J. Johnson,Suzanne R. Kesten,Robert G. MacKenzie,Peter J. Manley,Thomas A. Pugsley,Jon L. Wright,Lawrence D. Wise	13
13	The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents 1994 ·Journal of Medicinal Chemistry ·Jon L. Wright,Bradley W. Caprathe,Dennis M. Downing,Shelly A. Glase,Thomas G. Heffner,Juan C. Jaén,Stephen J. Johnson,Suzanne R. Kesten,Robert G. MacKenzie	18
14	2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents 1992 ·Journal of Medicinal Chemistry ·(unknown),James B. Dunbar,Suzanne R. Kesten,Joan L. Shillis,Leslie M. Werbel,Jacqueline Plowman,Donald L. Ward	42
15	Synthesis of the chiral 4-substituted 1-phenylcyclohexene PD137789 via intramolecular Wittig reaction 1992 ·The Journal of Organic Chemistry ·Stephen J. Johnson,Suzanne R. Kesten,Lawrence D. Wise	6
16	Cholinergic agents: 2-oxazolidinone analogues of the acetylcholine-receptor muscarinic agonist pilocarpine 1991 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Stephen J. Johnson,Suzanne R. Kesten,Michael R. Pavia,Robert E. Davis,Roy D. Schwarz,Linda L. Coughenour,Sharie L. Myers,David T. Dudley,(unknown)	4

About Suzanne R. Kesten

Suzanne R. Kesten is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Toxicology, having authored 16 papers that have together received 771 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). The work is most often cited by research in Toxicology (63 citations), Organic Chemistry (468 citations) and Pharmacology (198 citations). Suzanne R. Kesten has collaborated with scholars based in United States. Frequent co-authors include Lawrence D. Wise, Thomas G. Heffner, Thomas A. Pugsley, Jonathan L. Wright, Stephen J. Johnson, Kim Zoski, Thomas R. Belliotti, David J. Wustrow, John R. Rubin and Ann E. Corbin. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact